Syneos Health, Inc. (SYNH) Tops Q3 EPS by 5c, Offers Guidance

Syneos Health, Inc. (NASDAQ: SYNH) reported Q3 EPS of $1.22, $0.05 better than the analyst estimate of $1.17. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.34 billion.

GUIDANCE:

Syneos Health, Inc. sees FY2021 EPS of $4.35-$4.49, versus the consensus of $4.35. Syneos Health, Inc. sees FY2021 revenue of $5.2-5.28 billion, versus the consensus of $5.25 billion.

For earnings history and earnings-related data on Syneos Health, Inc. (SYNH) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• InspireMD (NSPR) Tops Q2 EPS by 1c
• Tesla to launch Cybercab in Austin this month - report